CME Learning Center

Breast Cancer

Implementing Therapeutic Intervention in High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Understanding the Prognostic Implications CME / ABIM MOC What recommendations do you make for patients with borderline risk of recurrence in the curative setting?
Medscape Education Oncology, September 2023
Metastatic HER2-Positive Breast Cancer Clinical Consult: Sequencing Therapies in Light of Progression CME / ABIM MOC How do we treat patients who need beyond third-line treatment for metastatic HER2-positive breast cancer? Drs Mahtani and Hamilton discuss how to manage these patients.
Medscape Education Oncology, September 2023
Intermingling Genomics and Ovarian Cancer Treatment Decisions CME / ABIM MOC Do you know which biomarkers can help you identify patients with advanced ovarian cancer (OC) who may benefit most from first-line maintenance with a poly(ADP-ribose) polymerase (PARP) inhibitor?
Medscape Education Oncology, September 2023
Clinical Overview of Oral Selective Estrogen Receptor Degraders CME / ABIM MOC Do you know how to incorporate oral selective estrogen receptor degraders (SERDs) in patients with hormone receptor (HR)-positive advanced breast cancer?
Medscape Education Oncology, September 2023
Antibody-Drug Conjugates in the Treatment of Metastatic HR-Positive, HER2-Negative Breast Cancer CME / ABIM MOC Exciting new data show that antibody drug conjugates are effective therapies in the management of HR-positive, HER2-negative breast cancer.
Medscape Education Oncology, September 2023
Shared Decision-Making in Oncology and Palliative Care CME / ABIM MOC / CE Giving therapeutic guidance to patients is difficult. Shared decision-making builds trust to support optimal outcomes when treatment isn't an option.
Medscape Education Oncology, August 2023
Adverse Event Management of TROP2-Targeting Antibody-Drug Conjugates (ADCs) CME / ABIM MOC / CE Do you know what the most common adverse events are with the various TROP2-targeting ADCs?
Medscape Education Oncology, July 2023
Testing Your Knowledge of Oral Selective Estrogen Receptor Degraders CME / ABIM MOC How well do you know the latest data on oral selective estrogen receptor degraders (SERDs)?
Medscape Education Oncology, July 2023
Changing Practice in HR-Positive/HER2-Negative Metastatic Breast Cancer: The Antibody-Drug Conjugate Edition CME / ABIM MOC Did you know that antibody-drug conjugates (ADCs) are a novel class of therapies now being used in the treatment of advanced or metastatic breast cancer (MBC)?
Medscape Education Oncology, June 2023
Expert Perspectives on Health Equity and Disparities in Immunotherapy Cancer Care CME / ABIM MOC / CE Are you up to date on the disparities in immunotherapy cancer care and ways to achieve health equity?
Medscape Education Oncology, June 2023
Designing and Using Antibody-Drug Conjugates to Treat Solid Tumors CME / ABIM MOC How much do you know about antibody-drug conjugates (ADCs) for solid tumor management?
Medscape Education Oncology, April 2023
Artificial Intelligence and Breast Cancer Imaging CME / ABIM MOC / CE What is the role of artificial intelligence in screening and diagnostics for breast cancer?
Medscape Education Radiology, April 2023
Conceptualizing Guidelines to Manage Patients With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer CME / ABIM MOC / CE What do the guidelines say about treating patients with early breast cancer at high risk for recurrence?
Medscape Education Oncology, March 2023
Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From the Updated Guidelines CME / ABIM MOC Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?
Medscape Education Oncology, March 2023
A Primer on Oral Selective Estrogen Receptor Degraders in Metastatic Hormone Receptor-Positive Breast Cancer CME / ABIM MOC Aromatase inhibitors (AIs), selective estrogen receptor modulators (SERMs), and selective estrogen receptor degraders (SERDs). How do they work and when should they be added to the treatment of metastatic hormone receptor (HR)-positive breast cancer?
Medscape Education Oncology, March 2023
Adjuvant Therapy in Hormone Receptor Positive/HER2-Negative Early Breast Cancer: Case Simulations CME / ABIM MOC Do you know the best approaches for identifying and managing high-risk, hormone receptor positive early breast cancer?
Medscape Education Oncology, March 2023
Minimizing Disparities in Breast Cancer to Enhance Equitable Cancer Care CME / ABIM MOC / CE Did you know Black women have the highest breast cancer mortality rate of any racial/ethnic group?
Medscape Education Oncology, March 2023
What's Your Take? Perspectives on Immunotherapy for Early-Stage Solid Tumors CME / ABIM MOC Did you know? Immunotherapy is now being used for the neoadjuvant and adjuvant treatment of solid tumors -- find out more here!
Medscape Education Oncology, February 2023
Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding the Data and Their Implications CME / ABIM MOC Will the newly reported monarchE data change your clinical practice for patients with HR+/HER- early breast cancer?
Medscape Education Oncology, January 2023
A Clinical Case Symposium: Targeted Therapies in HER2-Positive Breast Cancer CME / ABIM MOC Join this discussion to hear our experts discuss the management of human epidermal growth factor receptor 2 (HER2)-positive breast cancer across multiple lines of therapy.
Medscape Education Oncology, December 2022

Medscape Now! Hot Topics in Family Medicine September 2023 Part 2 CME / ABIM MOC / CE
Medscape Education Clinical Briefs, September 29, 2023
How Has the USPSTF Draft Updated Breast Cancer Screening? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, July 14, 2023
Is It Safe to Interrupt Endocrine Therapy for Breast Cancer to Attempt Pregnancy? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, June 9, 2023
Can Low-Cost Interventions Improve Cancer Screenings for Women in Remote Areas? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, June 2, 2023
Is Breast Cancer Risk Reduced After Bariatric Surgery? CME / ABIM MOC / CE
Medscape Education Clinical Briefs, May 26, 2023

CME Learning Center

Breast Cancer

Latest Clinical Briefs

About Breast Cancer

Further Reading